Logo image of STAY

Extended Stay America Inc (STAY) Stock Fundamental Analysis

NASDAQ:STAY - Nasdaq -

20.46  0 (0%)

After market: 20.46 0 (0%)

Fundamental Rating

1

Overall STAY gets a fundamental rating of 1 out of 10. We evaluated STAY against 135 industry peers in the Hotels, Restaurants & Leisure industry. Both the profitability and financial health of STAY have multiple concerns. STAY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

STAY had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 0.51%
ROE 1.82%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 19.7%
PM (TTM) 1.99%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

STAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

Based on the Altman-Z score of 0.84, we must say that STAY is in the distress zone and has some risk of bankruptcy.
A Debt/Equity ratio of 1.79 is on the high side and indicates that STAY has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z 0.84
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.46 indicates that STAY may have some problems paying its short term obligations.
A Quick Ratio of 0.46 indicates that STAY may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.46
Quick Ratio 0.46

3

3. Growth

3.1 Past

STAY shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -59.30%.
The earnings per share for STAY have been decreasing by -16.92% on average. This is quite bad
STAY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.19%.
STAY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.10% yearly.
EPS 1Y (TTM)-59.3%
EPS 3Y-27.57%
EPS 5Y-16.92%
EPS Q2Q%-42.86%
Revenue 1Y (TTM)-14.19%
Revenue growth 3Y-6.68%
Revenue growth 5Y-4.1%
Sales Q2Q%-2.53%

3.2 Future

Based on estimates for the next years, STAY will show a very strong growth in Earnings Per Share. The EPS will grow by 35.49% on average per year.
Based on estimates for the next years, STAY will show a small growth in Revenue. The Revenue will grow by 5.70% on average per year.
EPS Next Y61.05%
EPS Next 2Y46.61%
EPS Next 3Y39.9%
EPS Next 5Y35.49%
Revenue Next Year12%
Revenue Next 2Y8.4%
Revenue Next 3Y6.99%
Revenue Next 5Y5.7%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
STAY Yearly Revenue VS EstimatesSTAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
STAY Yearly EPS VS EstimatesSTAY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 58.46, the valuation of STAY can be described as expensive.
When comparing the Price/Earnings ratio of STAY to the average of the S&P500 Index (26.03), we can say STAY is valued expensively.
With a Price/Forward Earnings ratio of 25.05, STAY can be considered very expensive at the moment.
When comparing the Price/Forward Earnings ratio of STAY to the average of the S&P500 Index (21.94), we can say STAY is valued inline with the index average.
Industry RankSector Rank
PE 58.46
Fwd PE 25.05
STAY Price Earnings VS Forward Price EarningsSTAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.42
STAY Per share dataSTAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

STAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as STAY's earnings are expected to grow with 39.90% in the coming years.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y46.61%
EPS Next 3Y39.9%

2

5. Dividend

5.1 Amount

STAY has a Yearly Dividend Yield of 1.76%. Purely for dividend investing, there may be better candidates out there.
Compared to the average S&P500 Dividend Yield of 2.36, STAY is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.76%

5.2 History

The dividend of STAY decreases each year by -9.61%.
STAY has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-9.61%
Div Incr YearsN/A
Div Non Decr YearsN/A
STAY Yearly Dividends per shareSTAY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 0.5 1 1.5 2

5.3 Sustainability

DP0%
EPS Next 2Y46.61%
EPS Next 3Y39.9%

Extended Stay America Inc

NASDAQ:STAY (6/15/2021, 8:00:00 PM)

After market: 20.46 0 (0%)

20.46

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins Owners1.77%
Ins Owner Change0%
Market Cap3.74B
Analysts56.6
Price Target20.78 (1.56%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.76%
Yearly Dividend0.36
Dividend Growth(5Y)-9.61%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 58.46
Fwd PE 25.05
P/S 3.61
P/FCF N/A
P/OCF N/A
P/B 3.3
P/tB N/A
EV/EBITDA 14.42
EPS(TTM)0.35
EY1.71%
EPS(NY)0.82
Fwd EY3.99%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS5.66
BVpS6.21
TBVpSN/A
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.51%
ROE 1.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 19.7%
PM (TTM) 1.99%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.46
Quick Ratio 0.46
Altman-Z 0.84
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-59.3%
EPS 3Y-27.57%
EPS 5Y-16.92%
EPS Q2Q%-42.86%
EPS Next Y61.05%
EPS Next 2Y46.61%
EPS Next 3Y39.9%
EPS Next 5Y35.49%
Revenue 1Y (TTM)-14.19%
Revenue growth 3Y-6.68%
Revenue growth 5Y-4.1%
Sales Q2Q%-2.53%
Revenue Next Year12%
Revenue Next 2Y8.4%
Revenue Next 3Y6.99%
Revenue Next 5Y5.7%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A